Observational influenza vaccine active surveillance study: A Phase IV Prospective Multi-Centre Cohort Study to Evaluate the Reactogenicity of bioCSL’s influenza virus vaccine (2015/2016 formulation) (CSLCT-SAF-15-07)

Documents

Study protocol

Initial protocol

CSLCT-SAF-15-07_PASS protocol_abstract v1.0

Study results

Study results

RESULT SUMMARY for PASS 2015 - CSLCT-SAF-15-07_FINAL

Study report

Other information

Study, other information

LIST OF CENTRES WHERE THE STUDY IS BEING CONDUCTED

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

CSLCT-SAF-15-07_PASS protocol_abstract v1.0_Annex2 (checklist)